What is MedNet Solutions?
MedNet Solutions operates as a premier provider of eClinical software and digital infrastructure, specifically engineered to streamline the complexities of clinical trial management. Headquartered in Minnesota, the organization offers a unified platform that integrates electronic data capture, clinical data management, and patient-reported outcomes. By centralizing these critical functions, MedNet enables clinical research organizations and academic institutions to improve data integrity, ensure regulatory compliance, and accelerate study timelines. The company's core value proposition lies in its ability to reduce administrative friction through automation, thereby allowing researchers to focus on therapeutic innovation rather than manual data reconciliation. As the industry shifts toward decentralized and hybrid trial models, MedNet's cloud-native architecture provides the necessary scalability to support multi-site, global research initiatives across diverse therapeutic areas.
How much funding has MedNet Solutions raised?
MedNet Solutions has raised a total of $21.5M across 3 funding rounds:
Private Equity
$4M
Private Equity
$16.5M
Debt
$1M
Private Equity (2014): $4M with participation from Arrowroot Capital
Private Equity (2016): $16.5M led by Arrowroot Capital and Cohesive Capital Partners
Debt (2020): $1M supported by PPP
Key Investors in MedNet Solutions
Arrowroot Capital
Arrowroot Capital is a growth equity firm focused on software-as-a-service and internet-based businesses, providing capital and operational support to scale high-growth technology companies.
Cohesive Capital Partners
Cohesive Capital Partners is a private equity investment firm that engages in direct investments alongside prominent private equity firms, focusing on delivering insights and strategies within the private equity industry.
PPP
Public-Private Partnership
What's next for MedNet Solutions?
Looking ahead, the recent infusion of capital positions MedNet Solutions to further penetrate the rapidly evolving healthcare technology market. The strategic focus will likely center on enhancing the interoperability of its clinical trial automation tools and expanding its footprint in the decentralized trial space. By prioritizing the integration of advanced analytics and real-time monitoring capabilities, the firm is well-positioned to address the increasing demand for transparency and efficiency in drug development. As regulatory requirements become more stringent, MedNet's commitment to maintaining a compliant, high-performance digital ecosystem will be paramount in sustaining its competitive advantage. Future growth will likely be driven by continued investment in product development and the potential for strategic partnerships that broaden its reach within the global life sciences ecosystem.
See full MedNet Solutions company page
